These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21167392)

  • 1. Distribution of genes encoding virulence factors ompB2, ompCD, ompE, β-lactamase and serotype in pathogenic and colonizing strains of Moraxella catarrhalis.
    Mitov IG; Gergova RT; Ouzounova-Raykova VV
    Arch Med Res; 2010 Oct; 41(7):530-5. PubMed ID: 21167392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.
    Enright MC; McKenzie H
    J Med Microbiol; 1997 May; 46(5):360-71. PubMed ID: 9152030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moraxella catarrhalis, a human respiratory tract pathogen.
    Murphy TF; Parameswaran GI
    Clin Infect Dis; 2009 Jul; 49(1):124-31. PubMed ID: 19480579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of Moraxella catarrhalis from sputum specimens of Malaysian patients.
    Ahmad N; Cheong YM; Tahir HM
    Malays J Pathol; 1994 Jun; 16(1):63-7. PubMed ID: 16329578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Moraxella catarrhalis by DNA typing: evidence for a distinct subpopulation associated with virulence traits.
    Bootsma HJ; van der Heide HG; van de Pas S; Schouls LM; Mooi FR
    J Infect Dis; 2000 Apr; 181(4):1376-87. PubMed ID: 10762569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular characterization of BRO beta-lactamases of Moraxella catarrhalis strains isolated from carrier children].
    Köseoğlu O; Ergin A; Gürkan Aydin N; Hasçelik G
    Mikrobiyol Bul; 2004 Oct; 38(4):335-40. PubMed ID: 15700658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Moraxella catarrhalis infections of the lower respiratory tract in elderly patients.
    Tamang MD; Dey S; Makaju RK; Jha BK; Shivananda PG; Bhramadatan KN
    Kathmandu Univ Med J (KUMJ); 2005; 3(1):39-44. PubMed ID: 16401943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical, diagnostic and therapeutic aspects of Moraxella catarrhalis infections].
    Bourgeois F; Lambert-Zechovsky N; Bingen E
    Pathol Biol (Paris); 1993 Jun; 41(6):555-61. PubMed ID: 8247636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moraxella catarrhalis as a respiratory pathogen.
    Gupta N; Arora S; Kundra S
    Indian J Pathol Microbiol; 2011; 54(4):769-71. PubMed ID: 22234107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MID and UspA1/A2 of the human respiratory pathogen Moraxella catarrhalis, and interactions with the human host as basis for vaccine development.
    Riesbeck K; Tan TT; Forsgren A
    Acta Biochim Pol; 2006; 53(3):445-56. PubMed ID: 16964325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Moraxella catarrhalis outer membrane protein CD in bacterial cell morphology and autoaggregation.
    Saito R; Matsuoka S; Fujinami Y; Nonaka S; Ichinose S; Kubota T; Okamura N
    Res Microbiol; 2013 Apr; 164(3):236-43. PubMed ID: 23257176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Branhamella catarrhalis in respiratory infections].
    Marín Casanova P; García-Martos P; Fernández Fatou B; Bernal García F; Agudo Pérez E
    Rev Clin Esp; 1989 May; 184(8):399-400. PubMed ID: 2506614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and laboratory aspects of Moraxella catarrhalis bacteremia in children.
    Ahmed A; Broides A; Givon-Lavi N; Peled N; Dagan R; Greenberg D
    Pediatr Infect Dis J; 2008 May; 27(5):459-61. PubMed ID: 18360302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infections caused by Branhamella catarrhalis].
    Ejlertsen T; Schønheyder H
    Ugeskr Laeger; 1990 Feb; 152(7):475-7. PubMed ID: 2106743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of susceptibility patterns and BRO beta-lactamase types among clinical isolates of Moraxella catarrhalis.
    Esel D; Ay-Altintop Y; Yagmur G; Gokahmetoglu S; Sumerkan B
    Clin Microbiol Infect; 2007 Oct; 13(10):1023-5. PubMed ID: 17608812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex PCR assay that identifies the major lipooligosaccharide serotype expressed by Moraxella catarrhalis clinical isolates.
    Edwards KJ; Schwingel JM; Datta AK; Campagnari AA
    J Clin Microbiol; 2005 Dec; 43(12):6139-43. PubMed ID: 16333114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virulence factors of Moraxella catarrhalis outer membrane vesicles are major targets for cross-reactive antibodies and have adapted during evolution.
    Augustyniak D; Seredyński R; McClean S; Roszkowiak J; Roszniowski B; Smith DL; Drulis-Kawa Z; Mackiewicz P
    Sci Rep; 2018 Mar; 8(1):4955. PubMed ID: 29563531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moraxella catarrhalis: from interactions with the host immune system to vaccine development.
    Su YC; Singh B; Riesbeck K
    Future Microbiol; 2012 Sep; 7(9):1073-100. PubMed ID: 22953708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [THE PATHOGENIC POTENTIAL OF MORAXELLA CATARRHALIS AND STAPHYLOCOCCUS EPIDERMIDIS UNDER INFLAMMATORY PROCESSES OF UPPER RESPIRATORY TRACTS].
    Kraeva LA; Burgasova OA; Kunilova ES; Petrova IS; Tseneva GY; Bespalova GL
    Klin Lab Diagn; 2015 Nov; 60(11):58-61. PubMed ID: 26999868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiogram pattern of Moraxella catarrhalis isolates in acute exacerbation chronic obstructive pulmonary disease.
    Christol TJ; Shankar EM; Rao UA
    Chemotherapy; 2011; 57(1):94-6. PubMed ID: 21346354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.